Hi

Hi! How can I help you today?

Management of acute mi

Reading File
Finding Sources
Searching PubMed

"myocardial infarction"[MeSH Terms] AND "management"[MeSH Terms]

Finding Sources
Searching PubMed

"myocardial infarction" AND "reperfusion"

Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
I have enough content from Swanson's Family Medicine to compile a comprehensive answer. Let me now synthesize a complete, well-structured response.

Management of Acute Myocardial Infarction (AMI)

Initial Assessment & Classification

The first step is rapid ECG within 10 minutes of presentation. AMI is broadly classified as:
  • STEMI (ST-Elevation MI) - complete occlusion, requires immediate reperfusion
  • NSTEMI / UA (Non-ST-Elevation MI / Unstable Angina) - partial occlusion, managed with early invasive strategy

Immediate General Measures (MONA-B)

InterventionDetail
M - MorphineFor pain relief. Note: morphine may delay/reduce the antiplatelet effect of P2Y12 inhibitors and has been associated with increased in-hospital mortality in some analyses (low-confidence evidence)
O - OxygenSupplemental O2 for SpO2 < 90%; routine O2 in normoxic patients is no longer recommended (Cochrane evidence)
N - Nitrates (Nitroglycerin)For pain control; avoid in hypotension or RV infarction
A - Aspirin162-325 mg chewed immediately (stat)
B - Beta-blockersLimit infarct size; begin early unless contraindicated (cardiogenic shock, AV block, severe bronchospasm)

Reperfusion Strategy (The Core of STEMI Management)

Reperfusion is the cornerstone of STEMI treatment. There are two modalities:

1. Primary PCI (Gold Standard)

  • Preferred method for all STEMI patients
  • Target: within 90 minutes of first medical contact (door-to-balloon time)
  • Effective if symptoms < 12 hours duration
  • PCI with stenting is superior to balloon angioplasty alone
  • Limitations: requires experienced interventionalist, complications higher than elective PCI, arrhythmias (especially with RCA), up to 5% require emergency CABG

2. Thrombolysis (Second-Line)

Use only when PCI is not available within 120 minutes:
Indications:
  • Symptoms < 12 hours + ST elevation ≥ 1-2 mm in ≥ 2 contiguous limb leads
  • New left bundle branch block (LBBB)
  • ST depression in V1-V4 (posterior MI equivalent)
  • Patients < 75 years with anterior wall MI within 6 hours particularly benefit
Efficacy:
  • Streptokinase: ~55% recanalization rate
  • Alteplase (rt-PA): ~60% recanalization rate
  • 5-15% risk of early/late reocclusion
  • 1-2% risk of intracranial hemorrhage (40% mortality if occurs)
Absolute Contraindications to Thrombolysis:
  • Aortic dissection
  • History of cerebral hemorrhage
  • Cerebral aneurysm, AVM, or intracranial neoplasm
  • Thromboembolic stroke within 6 months
  • Active internal bleeding
If previously treated with streptokinase, use rt-PA (e.g., reteplase) for any future event.

Antiplatelet Therapy

Dual antiplatelet therapy (DAPT) for ALL STEMI patients:
  • Aspirin: 162-325 mg stat (load), then daily
  • Clopidogrel: 600 mg loading dose (or newer agents: ticagrelor 180 mg / prasugrel 60 mg loading)
  • The ISIS-2 trial showed aspirin + streptokinase reduced mortality by 42% without increased stroke or major bleeding

Anticoagulation

  • Unfractionated heparin (UFH) or Enoxaparin (LMWH)
  • Enoxaparin throughout the index hospitalization is preferred in many guidelines
  • Warfarin: reserved for patients at high risk for thromboembolism (e.g., large anterior MI, LV thrombus, AF)

Additional Pharmacotherapy

  • Magnesium sulfate: may be considered as analgesic/anxiolytic adjunct
  • Lidocaine prophylaxis: NOT indicated for prevention of dysrhythmias

Post-MI Management & Secondary Prevention

Before Discharge:

  • Submaximal stress ECG test
  • Echocardiogram (assess LV function, wall motion abnormalities)

Discharge Medications (all patients):

Drug ClassRationale
Aspirin (lifelong)Antiplatelet
Clopidogrel (12 months minimum)DAPT
Beta-blockerReduces remodeling, mortality
ACE inhibitor or ARBReduces afterload, prevents remodeling
StatinPleiotropic effects: plaque stabilization, reversal of endothelial dysfunction, reduced thrombogenicity and inflammation

Activity & Rehabilitation:

  • Exercise/cardiac rehab program: within 3-4 weeks
  • Return to work: within 8 weeks
  • Sexual intercourse: within 4 weeks
  • Involve spouse/significant other in recovery plan

ECG Changes - Quick Reference (Ganong's)

PhaseECG Finding
Minutes after occlusionST elevation (rapid repolarization + decreased resting membrane potential + delayed depolarization)
Hours-daysT-wave inversion
Days-weeksQ waves (marker of completed infarction)
OngoingST resolves; Q waves may persist permanently

Summary: The "90-Minute Rule"

"Time is muscle" - every 30 minutes of delay in reperfusion costs additional myocardium. The target of PCI within 90 minutes of first medical contact is the most important prognostic benchmark in STEMI management.

Sources: Swanson's Family Medicine Review, p. 113-114; Ganong's Review of Medical Physiology, 26th Ed.; ACC/AHA STEMI Guidelines (O'Gara PT et al., J Am Coll Cardiol. 2013)

Generate a quick-reference pocket card for AMI management

Generating Image
AMI Management Pocket Card
Here's your AMI quick-reference pocket card. It covers:
  • Initial steps - ECG timing and triage
  • Reperfusion strategy - PCI vs thrombolysis decision with time targets
  • Medications - both acute-phase and discharge drugs
  • Key time targets at a glance
  • The reminder "TIME = MUSCLE" at the bottom
You can save or print this directly. Let me know if you'd like any changes - different layout, added sections (e.g., contraindications, ECG changes, post-MI rehab), or a different color scheme.
This is a shared conversation. Sign in to Orris to start your own chat.